Keyphrases
Acute Myeloid Leukemia
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
90%
Granulocyte Colony-stimulating Factor (G-CSF)
81%
Graft-versus-host Disease (GvHD)
66%
Multiple Myeloma
46%
Hematopoietic Stem Cells
41%
Myelodysplastic Syndrome
39%
Plerixafor
30%
Transplantation
26%
T Cells
26%
Leukemia
25%
Tumor
25%
Non-Hodgkin Lymphoma
24%
Peripheral Blood
23%
Cancer Types
23%
Relapsed or Refractory
22%
Hematopoietic Stem Cell Mobilization
22%
Overall Survival
21%
Stem Cells
21%
Hematological Malignancies
21%
CD34+ Cells
21%
Stem Cell Mobilization
21%
Phase II Study
20%
Hematopoietic Cell Transplantation
19%
Chronic Myeloid Leukemia
19%
Chemotherapy
19%
Allogeneic Bone Marrow Transplantation
18%
Hematopoietic Stem Cell Transplantation
17%
Complete Remission
17%
Confidence Interval
17%
Cancer Genome Atlas
17%
AMD3100
17%
Unrelated Donor
16%
Relapsed or Refractory Acute Myeloid Leukemia
16%
Placebo
16%
Engraftment
16%
Chimeric Antigen Receptor T Cells (CAR-T)
15%
C-X-C Chemokine Receptor Type 4 (CXCR4)
15%
Autologous Transplantation
15%
Bone Marrow
15%
Allogeneic
14%
Stem Cell Transplantation
13%
Cytarabine
13%
Neutrophils
13%
Ruxolitinib
12%
CD34+
12%
Marrow
12%
Decitabine
12%
CXCR4 Antagonist
11%
Allogeneic Peripheral Blood Stem Cell Transplantation
11%
Immunology and Microbiology
Hematopoietic Cell
80%
Myeloid
57%
Graft-Versus-Host Disease
43%
Granulocyte Colony-Stimulating Factor
40%
T Cell
39%
Cell Transplantation
39%
CD34
39%
Multiple Myeloma
37%
Stem Cell
36%
Plerixafor
33%
Acute Graft Versus Host Disease
23%
Engraftment
22%
Conditioning
20%
Granulocyte Macrophage Colony-Stimulating Factor
20%
Drug Megadose
19%
Hematopoietic Stem Cell Transplantation
18%
Overall Survival
17%
Neutrophil
17%
Stem Cell Transplant
16%
CXCR4
16%
Cyclophosphamide
16%
Peripheral Blood Stem Cell
15%
Leukemia Cell
14%
Allograft
12%
Chronic Graft Versus Host Disease
12%
Autologous Stem Cell Transplantation
11%
Immunity
11%
Natural Killer Cell
11%
Allogeneic Stem Cell Transplantation
11%
Cytokine
11%
Autotransplantation
11%
Immunotherapy
10%
Platelet
9%
Mouse Model
9%
Granulocyte
9%
Cytomegalovirus
8%
Apheresis
8%
Bone Marrow Transplantation
8%
Regulatory T Cell
8%
Tumor Cell
8%
Chimeric Antigen Receptor T-Cell
7%
Allogeneic Bone Marrow Transplantation
7%
B Cell
7%
Granulocyte Macrophage Colony-Stimulating Factor Receptor
7%
Cell Line
7%
Stem Cell Transplantation
7%
Lymphocyte
7%
Disease Free Survival
6%
Allogeneic Peripheral Blood Stem Cell Transplantation
6%
T Cell Receptor
5%
Medicine and Dentistry
Hematopoietic Cell
60%
Acute Myeloid Leukemia
56%
Granulocyte Colony Stimulating Factor
34%
Transplantation
31%
Cell Transplantation
30%
Neoplasm
26%
Multiple Myeloma
25%
Diseases
25%
Myelodysplastic Syndrome
25%
Plerixafor
24%
Stem Cell Mobilization
23%
Graft Versus Host Reaction
19%
Malignant Neoplasm
19%
Hematopoietic Stem Cell Transplantation
19%
Stem Cell
17%
Overall Survival
17%
Hematologic Malignancy
16%
Platelet
15%
Chronic Myelogenous Leukemia
14%
Non-Hodgkin Lymphoma
14%
Stem Cell Transplant
14%
Leukemia
12%
Autologous Stem Cell Transplantation
12%
Acute Graft Versus Host Disease
12%
Chimeric Antigen Receptor T-Cell
12%
Neutrophil
12%
Stem Cell Therapy
12%
Receptor
12%
Allogeneic Stem Cell Transplantation
11%
Leukemia Cell
11%
Conditioning
11%
Cancer
11%
T Cell
11%
Engraftment
11%
Clinical Trial
9%
Cyclophosphamide
9%
Progenitor Cell
9%
Decitabine
9%
Placebo
9%
Cancer Types
9%
Peripheral Blood Stem Cell
9%
Immunity
8%
Immunotherapy
8%
Apheresis
8%
Autotransplantation
8%
Cell Therapy
8%
Whole Body Radiation
8%
The Cancer Genome Atlas
8%
Granulocyte
8%
Allogenic Bone Marrow Transplantation
7%